These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8822278)

  • 1. Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.
    Tuohy VK; Thomas DM; Haqqi T; Yu M; Johnson JM
    Autoimmunity; 1995; 21(3):203-14. PubMed ID: 8822278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK; Thomas DM
    J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes.
    Zhao ML; Fritz RB
    J Neuroimmunol; 1995 Sep; 61(2):179-84. PubMed ID: 7593553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein.
    Wang LY; Fujinami RS
    J Neuroimmunol; 1997 May; 75(1-2):75-83. PubMed ID: 9143240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
    Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
    Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
    Kumar V; Stellrecht K; Sercarz E
    J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
    Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
    J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopalmitoylation of myelin proteolipid protein epitopes enhances immunogenicity and encephalitogenicity.
    Greer JM; Denis B; Sobel RA; Trifilieff E
    J Immunol; 2001 Jun; 166(11):6907-13. PubMed ID: 11359852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.